Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.
The Global Mental Health Databank, a feasibility study, hopes to enable youth from the United Kingdom, South Africa, and India to work directly with mental health researchers to better understand how young people can manage their own mental health.
New study suggests that having COVID-19 increases a person\u2019s risk of developing psychiatric disorders, and that having a psychiatric disorder increases the chance of getting COVID-19. The study, published in The Lancet Psychiatry, used the TriNetX electronic health records of 69 million people in the USA including over 62,000 cases of COVID-19.
The Our Mental Wellness series is organised by the Department of Experimental Psychology. There will be 7 talks in this first series from experts in the field of mental health. Topics include stress and anxiety, sleep, depression and low mood, mistrust and paranoia, eating disorders, coping with trauma and bullying.
The effects of the digital therapeutic Sleepio (a digital sleep programme) may extend to depressive symptoms, according to new research published in the Journal of Sleep Research.
We are excited to announce that Catherine Harmer, Susannah Murphy and Liliana Capit\u00e3o are one of a select number of teams funded by Wellcome to review the evidence on which aspects of interventions really make a difference in preventing and treating youth anxiety and depression.
The news that children could be faced with in the current COVID-19 pandemic may seem almost unspeakable. But, together, we must find words, and ways, to give voice to their experience and prevent\u202fmillions of\u202fchildren\u202fstruggling\u202fwith\u202ftheir fears and\u202funcertainty\u202falone, say authors of a new Comment published in The Lancet Child and Adolescent Health.
The Oxford University COSIE study (COvid-19, Social Isolation and Emotion) is an online study which asked people about their experiences during the coronavirus lockdown in late April 2020, while also using objective tests of psychological function to measure vulnerability to mental illness such as depression.
Supporting natural mood regulation is a new direct target for developing novel treatments, optimising existing ones and integrating drug and psychotherapies to reduce the disease burden of depression, according to new research, published in JAMA Psychiatry, from the Department of Psychiatry, University of Oxford.
Wearable devices offer exciting opportunities to longitudinally detect and track multi-modal stress and symptoms of disease in an objective and unobtrusive way.
The US Food and Drug Administration (FDA) has recently licensed a form of ketamine \u2013 esketamine \u2013 as a treatment for depression which is resistant to other treatments. It is administered as a nasal spray in a clinic, initially twice a week, then weekly or fortnightly. Regular doses of the drug are necessary to prevent relapse.
Depression is very common in adolescence and is associated with a high risk of recurrence and suicide. Adolescents with depression experience the same symptoms as adults, such as sadness and fatigue, but some key differences exist. Depressed youth often feel irritable rather than or in addition to feeling low.
Researchers from McGill University and the University of Oxford carried out a systematic review and meta-analysis of the best existing evidence and analysed 23,317 individuals (from 11 international studies) to see whether use of cannabis in young people is associated with depression, anxiety and suicidality in early adulthood.
Professor of Cognitive Neuroscience, Catherine Harmer, from Oxford University Department of Psychiatry is presenting this year's lecture on 'How do antidepressants work?'.
![\"A](\"https://www.psych.ox.ac.uk/news/ssri-treatment-in-young-people-with-depression-and-anxiety/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n